Tristel plc
Company Profile
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets annual revenue growth of between 10% and 15% and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
.png "TSTL Company Summary (January 2025)")
Investor Access
The Company will announce its interim results for the six months ended 31 December 2024 on Monday 24 February 2025.
Two presentations will take place on Monday 24 February 2025 at the following times:
- Investor Meet Company online presentation at 11.30am. Investors can sign up to Investor Meet Company for free and add to meet Tristel plc via: https://www.investormeetcompany.com/tristel-plc/register-investor
- In-person investor presentation at 4.30pm at 85 Gresham Street, London, EC2V 7NQ. If you would like to attend, please contact Walbrook PR on 020 7933 8780 or email [email protected].
- Online - Monday 24 February 2025 at 11.30am
- In-person - Monday 24 February 2025 at 4.30pm
| Event | Date |
| Year End | 30 June |
| Half Year End | 31 December |
| Preliminary Results* | October |
| Interim Results* | February |
| AGM* | December |
* Months based on previous announcements of this kind
